Cargando…

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers

Despite recent improvements in survival, metastatic castration-resistant prostate cancers (mCRPCs) remain lethal. Alterations in genes involved in the homologous recombination repair (HRR) pathway are associated with poor prognosis. Poly-ADP-ribose polymerase (PARP) inhibitors (PARPis) have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teyssonneau, Diego, Thiery-Vuillemin, Antoine, Dariane, Charles, Barret, Eric, Beauval, Jean-Baptiste, Brureau, Laurent, Créhange, Gilles, Fiard, Gaëlle, Fromont, Gaëlle, Gauthé, Mathieu, Ruffion, Alain, Renard-Penna, Raphaële, Mathieu, Romain, Sargos, Paul, Rouprêt, Morgan, Ploussard, Guillaume, Roubaud, Guilhem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952857/ https://www.ncbi.nlm.nih.gov/pubmed/35330059 http://dx.doi.org/10.3390/jcm11061734

Ejemplares similares

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
por: Gauthé, Mathieu, et al.
Publicado: (2021)

Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review
por: Manceau, Cécile, et al.
Publicado: (2021)

Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
por: Gasmi, Anis, et al.
Publicado: (2021)

Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
por: Baboudjian, Michael, et al.
Publicado: (2022)

Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
por: Sargos, Paul, et al.
Publicado: (2021)

Same-day-discharge Robot-assisted Radical Prostatectomy: An Annual Countrywide Analysis
por: Ploussard, Guillaume, et al.
Publicado: (2021)

A 5-Year Contemporary Nationwide Evolution of the Radical Prostatectomy Landscape
por: Ploussard, Guillaume, et al.
Publicado: (2021)

Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU)
por: Saouli, Amine, et al.
Publicado: (2023)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
por: Touzani, Alae, et al.
Publicado: (2022)

Prostate cancer and PARP inhibitors: progress and challenges
por: Teyssonneau, Diego, et al.
Publicado: (2021)

Chromogranin A: a useful biomarker in castration-resistant prostate cancer
por: Ploussard, Guillaume, et al.
Publicado: (2022)

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction
por: Ploussard, Guillaume, et al.
Publicado: (2020)

Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy
por: Sargos, Paul, et al.
Publicado: (2021)

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017)

(68)Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact
por: Fourquet, Aloÿse, et al.
Publicado: (2020)

How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position
por: Bossi, Alberto, et al.
Publicado: (2023)

Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
por: Sargos, Paul, et al.
Publicado: (2016)

Restaging the Biochemical Recurrence of Prostate Cancer with [(68)Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
por: Fourquet, Aloÿse, et al.
Publicado: (2021)

Actualisation du risque lié à la corticothérapie en association à l’acétate d’abiratérone en période de pandémie COVID-19
por: Rozet, F., et al.
Publicado: (2021)

Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence
por: Giraud, Nicolas, et al.
Publicado: (2021)

Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic
por: Diamand, Romain, et al.
Publicado: (2020)

Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study
por: Fiard, Gaelle, et al.
Publicado: (2020)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

Role and Training of the Bedside Surgeon in Robotic Surgery: A Survey Among French Urologists-in-Training
por: Lagrange, Francois, et al.
Publicado: (2022)

Automatic segmentation of prostate zonal anatomy on MRI: a systematic review of the literature
por: Wu, Carine, et al.
Publicado: (2022)

Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study
por: Windisch, Olivier, et al.
Publicado: (2022)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
por: Vela, Carla, et al.
Publicado: (2022)

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy
por: Manceau, Cécile, et al.
Publicado: (2020)

The BETTY Score to Predict Perioperative Outcomes in Surgical Patients
por: Baboudjian, Michael, et al.
Publicado: (2023)

High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
por: Jeantet, Marion, et al.
Publicado: (2016)

Online Public Interest in Urological Cancers During the COVID-19 Pandemic: What Can “Dr. Google” Teach Us?
por: Khene, Zine-Eddine, et al.
Publicado: (2022)

MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy
por: Manceau, Cécile, et al.
Publicado: (2020)

The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is “Safe Better than Sorry”?
por: Pradère, Benjamin, et al.
Publicado: (2020)

Subsphincteric Anastomosis During Laparoscopic Robot-Assisted Radical Prostatectomy and Its Positive Impact on Continence Recovery
por: Almeras, Christophe, et al.
Publicado: (2020)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

Hepatitis C Transmission after Prostate Biopsy
por: Ferhi, Karim, et al.
Publicado: (2013)

Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group
por: Marcq, Gautier, et al.
Publicado: (2022)

Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy
por: Renard-Penna, Raphaële, et al.
Publicado: (2022)

Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario
por: Cancel, Mathilde, et al.
Publicado: (2022)

Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study
por: Jouve, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h3kiidq44449cs1pljvqdlhpsi